Related Experiment Video
Updated: Aug 9, 2026
08:19
Isolation of Leukocytes from the Human Maternal-fetal Interface
Published on: May 21, 2015
[Hairy cell leukemia in pregnancy]
Izabella Kopeć1, Romuald Debski, Marzena Samsel
1Instytut Hematologii i Transfuzjologii w Warszawie.
Ginekologia Polska
|March 29, 2006
Summary
Hairy cell leukemia (HCL) in pregnancy is rare. This case study shows successful pregnancy management with interferon-alpha (IFN-alpha) and prednisone, resulting in a healthy infant and partial remission of HCL.
Area of Science:
- Hematology
- Oncology
- Obstetrics
Background:
- Hairy cell leukemia (HCL) is a rare chronic lymphoid leukemia.
- Pregnancy complicated by HCL is exceptionally rare, with limited documented cases.
- This report details a unique case of HCL diagnosed during pregnancy.
Observation:
- A 36-year-old woman diagnosed with HCL at 14 weeks gestation.
- Treatment initiated at 18 weeks with subcutaneous interferon-alpha (IFN-alpha) and oral prednisone.
- IFN-alpha was well-tolerated throughout the pregnancy.
Findings:
- Partial remission of HCL was achieved following IFN-alpha therapy.
- The pregnancy progressed normally, culminating in a healthy infant delivery via cesarean section at 39 weeks.
- The infant had a normal birth weight (3460g) and Apgar score of 10.
- No HCL infiltration was observed in the placenta.
Implications:
- Interferon-alpha and prednisone can be safely and effectively used to manage HCL during pregnancy.
- This approach allows for a normal pregnancy course and healthy infant delivery.
- Further research into optimal HCL management strategies during gestation is warranted.